Florida Medical Cannabis Conference Agenda

---

7:30 am – 6:30 pm

Registration Open

7:30 am – 8:00 am

Continental Breakfast: Industry Engagement Pavilion

8:00 am – 10:00 am

FMCCE Opening Session:

Welcome: Gene Jones, Executive Director, Can-Ed, Inc.

Moderator: Dr. William Troutt, NMD, Lead Medical Director, Trulieve

Florida Medical Cannabis Legislative Update

Ron Watson, President, Watson Strategies and Northwest  Area Sales Representative, MÜV by Verano

Minor Cannabinoids: Mechanisms and Clinical Reports

Dr. Bonni Goldstein, MD, CEO & Co-founder, Goldstein Wellness 

Patients Out of Time Presents Cannabis and Psychedelic Researchers Hall of Fame

Scheril Murray Powell, Esq., Executive Director, Patients Out of Time 

10:00 am – 10:30 am

Refreshment Break - Industry Engagement Pavilion

10:30 am – 12:00 pm

Session I:

Advancing the Science of Medical Cannabis: Research from Real‑World Data to Clinical Trials

Panelists:

Dr. Catalina Lopez‑Quintero, MD (IMG), Ph.D., Assistant Professor, Department of Epidemiology, College of Public Health & Health Professions, and College of Medicine, University of Florida

Dr. Juan Pérez‑Carreno, MD (IMG), MS, MBE, Ph.D. – PhD candidate, Department of Epidemiology, College of Public Health & Health Professions, and College of Medicine, University of Florida

Dr. Md Mahmudul Hasan, Ph.D., Assistant Professor, Department of Pharmaceutical Outcomes and Policy, University of Florida

Dr. Karina Villalba, Ph.D., Assistant Professor, Department of Population Health Sciences, College of Medicine, University of Central Florida

12:00 pm – 1:00 pm

Lunch Provided - Location TBD

1:00 pm – 3:00 pm

Session II:

Precision Cannabis: Dosing, Safety, and Clinical Decision-Making in 2026

Moderator: Dr. Stephanie Johnson, DO, Founder/Owner, Kaya Life Enterprise

Cannabinoid Dosing Strategies: Precision, Personalization, and Patient-Centered Care

Sabrina G. Fayaz, M.S., MCST, Director, Master of Science in Medical Cannabinoid Therapeutics (MCT) Program, LECOM

Safety, Dosing, and Quality — From Device Toxicology to Edible Pharmacokinetics A 2026 Clinical Framework for Florida Practitioners

Dr. Joseph Rosado, MD, MBA, JOSEPH ROSADO, MD, LLC

Deprescribing Patterns After Medical Cannabis Initiation in Older Adults with Polypharmacy

Dr. Lihi Bar-Lev Schleider, Ph.D., Research Department, Tikun-Olam

The Case for Cannabinoids as Multimodal Adjuncts in Chronic Pain

Dr. Deondra Asike, MD, Board Certified in Anesthesiology and Pain Medicine, Founder, National Pain ReLEAF

3:00 pm – 3:30 pm

Refreshment Break: Industry Engagement Pavilion

3:30 pm – 5:00 pm

Session III:

Florida A&M University Medical Marijuana Education and Research Initiative (MMERI): Quality, Safety, and Public Awareness of Regulated and Unregulated Cannabis Products

Panelists:

GP Mendie, Assistant Vice President for Research Florida A&M University (FAMU) and  Executive Director, Medical Marijuana Education and Research Initiative (MMERI)

Dr. Mandip S. Sachdeva, Professor, Florida A&M University (FAMU), College of Pharmacy and Pharmaceutical Sciences 

Dr. Jamal A. Brown, PharmD., Associate Professor of Pharmacy Practice, Florida A&M University (FAMU), College of Pharmacy and Pharmaceutical Sciences

Michelle Wilson, MBA, FCCM, Associate Director, Florida A&M University (FAMU), Medical Marijuana Education and Research Initiative (MMERI)

Anthony Washington, CPM, Statewide Program Outreach Coordinator, Florida A&M University (FAMU), Medical Marijuana Education and Research Initiative (MMERI)

5:00 pm – 6:30 pm

Reception: Industry Engagement Pavilion